Advertisement

Clinical Risk Factors Associated With Small Renal Mass Malignant Histology in a Multi-Ethnic Population Undergoing Partial Nephrectomy

      Abstract

      Introduction

      Small renal masses (SRMs) are often incidentally diagnosed, and a large proportion are malignant. However, there is a paucity of data describing predictors of malignancy in minority patients with SRMs. Thus, our goal was to examine clinical risk factors associated with SRM malignant histology in patients undergoing partial nephrectomy (PN) a diverse, urban academic center.

      Materials and Methods

      Patients with a SRM undergoing PN at a single institution between 2010 to 2018 were reviewed. Demographic, clinical, and imaging characteristics were compared to pathology results. Logistic regression was used to examine associations between demographic/clinical variables for malignant and high-grade histology.

      Results

      In total, 331 patients who underwent PN for SRM were included. Of those, 264 (79.8%) had malignant histology while 67 (20.2%) had benign histology. The proportions of men and of current smokers were significantly higher among patients with malignant histology. In multivariate models, non-Hispanic Black (NHB) patients had increased odds of having malignant histology (OR 2.46, 95% CI: 1.01-5.99, P = .048) and current smokers (OR = 4.02; 95% CI 1.14-14.18, P = .031). Hispanic patients had a 3-fold increased risk of high-grade RCC (OR 3.06, 95% CI: 1.19-7.87, P = 0.02) compared to Non-Hispanic White patients.

      Conclusion

      In our population, male sex, smoking, and NHB race/ethnicity was associated with an increased risk of malignancy in patients undergoing partial nephrectomy for SRM. Older age and Hispanic race/ethnicity were associated with high grade RCC. Our results suggest that urologists should exercise a higher level of vigilance in managing and treating SRM among NHB and Hispanic patients.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinical Genitourinary Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bray F
        • Ferlay J
        • Soerjomataram I
        • Siegel RL
        • Torre LA
        • Jemal A.
        Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
        CA: Cancer J Clin. 2018; 68: 394-424https://doi.org/10.3322/caac.21492
        • King SC
        • Pollack LA
        • Li J
        • King JB
        • Master VA.
        Continued increase in incidence of renal cell carcinoma, especially in young patients and high grade disease: United States 2001 to 2010.
        J Urol. 2014; 191: 1665-1670https://doi.org/10.1016/j.juro.2013.12.046
        • Kane CJ
        • Mallin K
        • Ritchey J
        • Cooperberg MR
        • Carroll PR.
        Renal cell cancer stage migration: analysis of the national cancer data base.
        Cancer. 2008; 113: 78-83https://doi.org/10.1002/cncr.23518
        • Johnson DC
        • Vukina J
        • Smith AB
        • et al.
        Preoperatively misclassified, surgically removed benign renal masses: a systematic review of surgical series and United States population level burden estimate.
        J Urol. 2015; 193: 30-35https://doi.org/10.1016/j.juro.2014.07.102
        • Frank I
        • Blute ML
        • Cheville JC
        • Lohse CM
        • Weaver AL
        • Zincke H.
        Solid renal tumors: an analysis of pathological features related to tumor size.
        J Urol. 2003; 170: 2217-2220https://doi.org/10.1097/01.ju.0000095475.12515.5e
        • Kim JH
        • Li S
        • Khandwala Y
        • Chung KJ
        • Park HK
        • Chung BI.
        Association of prevalence of benign pathologic findings after partial nephrectomy with preoperative imaging patterns in the United States from 2007 to 2014.
        JAMA Surg. 2019; 154: 225-231https://doi.org/10.1001/jamasurg.2018.4602
        • Bagrodia A
        • Darwish OM
        • Rapoport Y
        • Margulis V.
        Risk prediction in the management of small renal masses.
        Curr Opin Urol. 2012; 22: 347-352https://doi.org/10.1097/MOU.0b013e328355ede9
        • Lane BR
        • Babineau D
        • Kattan MW
        • et al.
        A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy.
        J Urol. 2007; 178: 429-434https://doi.org/10.1016/j.juro.2007.03.106
        • Kates M
        • Korets R
        • Sadeghi N
        • Pierorazio PM
        • McKiernan JM.
        Predictors of locally advanced and metastatic disease in patients with small renal masses.
        BJU Int. 2012; 109: 1463-1467https://doi.org/10.1111/j.1464-410X.2011.10553.x
        • Kutikov A
        • Egleston BL
        • Wong YN
        • Uzzo RG.
        Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram.
        J Clin Oncol. 2010; 28: 311-317https://doi.org/10.1200/jco.2009.22.4816
        • Tsivian M
        • Mouraviev V
        • Albala DM
        • et al.
        Clinical predictors of renal mass pathological features.
        BJU Int. 2011; 107: 735-740https://doi.org/10.1111/j.1464-410X.2010.09629.x
        • Suarez-Sarmiento A
        • Yao X
        • Hofmann JN
        • et al.
        Ethnic disparities in renal cell carcinoma: an analysis of Hispanic patients in a single-payer healthcare system.
        Int J Urol. 2017; 24: 765-770https://doi.org/10.1111/iju.13424
        • Donat SM
        • Diaz M
        • Bishoff JT
        • et al.
        Follow-up for clinically localized renal neoplasms: AUA guideline.
        J Urol. 2013; 190: 407-416https://doi.org/10.1016/j.juro.2013.04.121
        • Bellin E
        • Fletcher DD
        • Geberer N
        • Islam S
        • Srivastava N.
        Democratizing information creation from health care data for quality improvement, research, and education-the Montefiore medical center experience.
        Acad Med. 2010; 85: 1362-1368https://doi.org/10.1097/ACM.0b013e3181df0f3b
        • Delahunt B
        • Cheville JC
        • Martignoni G
        • et al.
        The international society of urological pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters.
        Am J Surg Pathol. 2013; 37: 1490-1504https://doi.org/10.1097/PAS.0b013e318299f0fb
        • Capitanio U
        • Bensalah K
        • Bex A
        • et al.
        Epidemiology of renal cell carcinoma.
        Eur Urol. 2019; 75: 74-84https://doi.org/10.1016/j.eururo.2018.08.036
        • Organ M
        • MacDonald LP
        • Jewett MAS
        • et al.
        Classification tree for the prediction of malignant disease and the prediction of non-diagnostic biopsies in patients with small renal masses.
        Can Urol Assoc J. 2019; 13: 115-119https://doi.org/10.5489/cuaj.5196
        • Akdogan B
        • Gudeloglu A
        • Inci K
        • Gunay LM
        • Koni A
        • Ozen H.
        Prevalence and predictors of benign lesions in renal masses smaller than 7 cm presumed to be renal cell carcinoma.
        Clin Genitourin Cancer. 2012; 10: 121-125https://doi.org/10.1016/j.clgc.2012.01.005
        • Bagrodia A
        • Harrow B
        • Liu ZW
        • et al.
        Evaluation of anatomic and morphologic nomogram to predict malignant and high-grade disease in a cohort of patients with small renal masses.
        Urol Oncol. 2014; 32 (37.e17-23)https://doi.org/10.1016/j.urolonc.2013.03.003
        • Koo KC
        • Yoo H
        • Shin TY
        • et al.
        External validation of the RENAL nephrometry score nomogram for predicting high-grade renal cell carcinoma in solid, enhancing, and small renal masses.
        World J Urol. 2014; 32: 249-255https://doi.org/10.1007/s00345-013-1159-3
        • Steffens S
        • Ringe KI
        • Schroeer K
        • et al.
        Does overweight influence the prognosis of renal cell carcinoma? results of a multicenter study.
        Int J Urol. 2013; 20: 585-592https://doi.org/10.1111/iju.12000
        • Hakimi AA
        • Furberg H
        • Zabor EC
        • et al.
        An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma.
        J Natl Cancer Inst. 2013; 105: 1862-1870https://doi.org/10.1093/jnci/djt310
        • Gan CL
        • Heng DYC.
        New insights into the obesity paradox in renal cell carcinoma.
        Nat Rev Nephrol. 2020; 16: 253-254https://doi.org/10.1038/s41581-020-0264-y
        • Ito R
        • Narita S
        • Huang M
        • et al.
        The impact of obesity and adiponectin signaling in patients with renal cell carcinoma: a potential mechanism for the "obesity paradox".
        PLoS One. 2017; 12e0171615https://doi.org/10.1371/journal.pone.0171615
        • Sanchez A
        • Furberg H
        • Kuo F
        • et al.
        Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study.
        Lancet Oncol. 2020; 21: 283-293https://doi.org/10.1016/s1470-2045(19)30797-1
        • Chow WH
        • Shuch B
        • Linehan WM
        • Devesa SS.
        Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics.
        Cancer. 2013; 119: 388-394https://doi.org/10.1002/cncr.27690
        • Mafolasire A
        • Yao X
        • Nawaf C
        • et al.
        Racial disparities in renal cell carcinoma: a single-payer healthcare experience.
        Cancer Med. 2016; 5: 2101-2108https://doi.org/10.1002/cam4.755
        • Kates M
        • Whalen MJ
        • Badalato GM
        • McKiernan JM.
        The effect of race and gender on the surgical management of the small renal mass.
        Urol Oncol. 2013; 31: 1794-1799https://doi.org/10.1016/j.urolonc.2012.05.005
        • Sims JN
        • Yedjou CG
        • Abugri D
        • et al.
        Racial disparities and preventive measures to renal cell carcinoma.
        Int J Environ Res Public Health. 2018; 15https://doi.org/10.3390/ijerph15061089
        • Wassim BM
        • Shelia DZ
        • Melanie B
        • Paul R
        The association of baseline health and gender with small renal mass pathology.
        Can J Urol. 2014; 21: 7271-7276
        • Wong KJ
        • Shusterman M
        • Goel S
        • Negassa A
        • Lin J
        • Gartrell BA.
        Racial diversity among histology of renal cell carcinoma at an urban medical center.
        Clin Genitourin Cancer. 2021; 19: e166-e170https://doi.org/10.1016/j.clgc.2020.12.010
        • Valencia CI
        • Asmar S
        • Hsu CH
        • et al.
        Renal cell carcinoma health disparities in stage and mortality among American Indians/Alaska natives and Hispanic Americans: comparison of national cancer database and Arizona cancer registry data.
        Cancers (Basel). 2021; 13https://doi.org/10.3390/cancers13050990